Specifically, the downregulation of CAT expression has been shown in pancreatic cancer cells and mouse skin tumors [16,17], but upregulation of CAT expression has been reported in melanoma [18], colon cancer [19], gastric adenocarcinoma [20], and GBM [21] cells. The gene discussed is CAT; the disease is gastric adenocarcinoma.